A large investment group with office in USA and Europe have invested in 265 companies across 55 countries. The firm is very active in the pharmaceutical and biotech industry, with around 70% of their portfolio being within these sectors. The firm has activity in listed companies, where they have interest in being a minority shareholder, with an investment size ranging from $10M to $200M. The firm is also interested in pre- IPO companies, with an investment size ranging from $5M to $200M in the form of equity, however the firm is only interested in companies that are planning on being listed in the stock exchange in the next 12 – 24 months. The firm has been successful in listing companies in the stock exchange, having done so with 4 companies so far, so their goal is to invest in companies who have that strategy. The firm is open to global opportunities.
The firm is looking for opportunities within the therapeutics, diagnostics and medical device sectors. The firm is agnostic in terms of subsector and indication, and will invest in all three classes of medical devices. The firm is open to pre-clinical companies.
The firm is open to all types of management teams with the caveat that the company must be planning on going public in the next 2 years. The firm prefers to lead investments and does not require a board seat.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply